Icon Cancer Care Chermside

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Prostate cancer2 trials
• Acute myeloid leukaemia1 trial
• Chronic myeloid leukaemia1 trial
• Lung cancer1 trial
• Mesothelioma1 trial
• Myelodysplastic syndromes1 trial

Phase

• Phase 34 trials

Status

• Completed3 trials
• Active, not recruiting1 trial

Lead sponsor

• Pfizer2 trials
• PrECOG, LLC.1 trial
• Takeda1 trial

Running trials

• Active, not recruiting

  Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)

  NCT02319837· Phase 3· Pfizer· Source

Closed trials

• Completed

  DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma

  NCT04334759· Phase 3· PrECOG, LLC.· Source

• Completed

  Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)

  NCT03268954· Phase 3· Takeda· Source

• Completed

  Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer

  NCT02003924· Phase 3· Pfizer· Source